The only deadline IMU set was the clinical trial updates for VAXINIA and OASIS will be released this quarter and also the registrational clinical trial for Azer-Cel was meant to be started by now but understandable there's a delay of 12 months as the first Cohort without IL-2 wasn't performing as well. If you don't think receiving Fast Track designation and ODD are excellent progress then you don't know how biotech start-up stock work.
I don't recall them setting any deadline for the clinical trial for VAXINIA so we waited 18 months before they got released and the pps got smashed during that time. Same is happening now but the pps has gone to a low of 3c instead of 4c.
IMU Price at posting:
3.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)